NCT05394675View on ClinicalTrials.gov

A Study of DS-9606a in Patients With Advanced Solid Tumors

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

February 19, 2026

Study Completion Date

February 19, 2026

Conditions
Advanced CancerMetastatic CancerOvarian CancerGerm Cell Tumor
Interventions
DRUG

DS-9606a

Intravenous infusion

Trial Locations (7)

33916

Florida Cancer Specialists & Research Institute, LLC, Fort Myers

37203

SCRI Oncology Partners, Nashville

48201

Barbara Ann Karmanos Cancer Institute, Detroit

77030

MD Anderson Cancer Center, Houston

80216

SCRI at HealthONE, Denver

W1G 6AD

Sarah Cannon Research Institute UK, London

SM2 5PT

The Royal Marsden NHS Trust, Sutton

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY